APDN, EvviVax Announce Publication of Positive Preclinical Data for Linear DNA™ Platform Approach to Cancer Immunotherapy
February 17th, 2022
APDN, EvviVax Announce Publication of Positive Preclinical Data for Linear DNA™ Platform Approach to Cancer Immunotherapy
February 17th, 2022

Our new ticker symbol is ‘BNBX’. Learn more here.